SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Sunil Healthcare informs about newspaper clipping

16 Feb 2023 Evaluate

Pursuant to Regulation 47 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Sunil Healthcare has informed that the Company has published Un-audited Financial Results for 3rd quarter/Nine months ended on December 31, 2022 in newspapers, ‘Pioneer’ on February 16, 2023 both Hindi & English edition. In this regard, it has enclosed newspapers clipping of the results published on February 16, 2023.

The above information is a part of company’s filings submitted to BSE.


Sunil Healthcare Share Price

65.99 1.99 (3.11%)
06-May-2026 10:10 View Price Chart
Peers
Company Name CMP
BASF India 3660.00
Tata Chemicals 821.55
SRF 2627.30
Pidilite Inds. 1387.00
Deepak Nitrite 1767.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×